S

Smith & Nephew plc
D

SNN

25.300
USD
0.26
(1.02%)
مغلق
حجم التداول
125,197
الربح لكل سهم
2
العائد الربحي
2.97
P/E
36
حجم السوق
11,030,644,633
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -2.210
    (-1.27%)
    171.520 USD
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    GSK
    GSK
    -0.035
    (-0.10%)
    33.430 USD
    JNJ
    JNJ
    -0.740
    (-0.50%)
    147.060 USD
    LLY
    LLY
    -32.08
    (-4.23%)
    726.07 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    NVS
    NVS
    -0.320
    (-0.33%)
    97.530 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    المزيد
الأخبار
المقالات

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.